Skip to content
OpenCapital
Get started

Bioventus BVS International Segment — Adjusted cost of sales

Similar metrics at other companies

MillerKnoll logo
MLKNInternational Contract — Adjusted cost of sales
$101.4M+8.7%
Mattel logo
MATInternational — Cost of Sales
$202.73M+15.5%
Daktronics logo
DAKTInternational — Cost of Sales
$10.7M-19.6%
ALH
ALHInternational — Cost of Sales
$64.72M+10.6%
MSA
MSAInternational — Cost of products sold
$79.73M+11.5%
Carter's logo
CRIInternational — Cost of goods sold
$50.97M+7.4%

Other financials

Income statement

See full
Revenue$132.1M+6.6%
Gross profit$90.8M+9.3%
Operating income$8.4M+72.8%
Net income$3.1M+218%
EPS (diluted)$0.04+200%

Balance sheet

See full
Cash & equivalents$35.8M+57.2%
Total debt$288.4M-21.2%
Total equity$188.9M+27.5%
Total assets$650.5M-5.9%

Cash flow

See full
Operating cash flow$8.9M+146%
CapEx$574.0K-30.5%
Free cash flow$8.4M+141%

Valuation

See full
Market cap$659.19M+51.7%
Enterprise value$911.76M+17.2%
P/E23.1×—
P/S1.1×+0.4×

Profitability

See full
Gross margin68.7%+1.2pp
Operating margin10%—
Net margin4.9%+3.2pp
FCF margin17.5%+13.2pp

Returns & leverage

See full
Return on equity16.9%+10.9pp
Debt / equity1.5×-0.9×
Current ratio1.7×+0.3×

Where this comes from

Reported directly by Bioventus in its filing.

Tagged under the XBRL concept bvs:AdjustedCostOfSales.

The official record: Bioventus’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Bioventus's international segment — adjusted cost of sales.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Bioventus's international segment — adjusted cost of sales?
Bioventus (BVS) reported international segment — adjusted cost of sales of $6.34M in Q1 2026.
How has Bioventus's international segment — adjusted cost of sales changed year-over-year?
Bioventus's international segment — adjusted cost of sales increased by 22.8% year-over-year, from $5.16M to $6.34M.
What is the long-term trend for Bioventus's international segment — adjusted cost of sales?
Over 3 years (2022 to 2025), Bioventus's international segment — adjusted cost of sales has grown at a 7.8% compound annual growth rate (CAGR), from $19.85M to $24.86M.
What does international segment — adjusted cost of sales mean?
Reflects the direct costs associated with producing and delivering products sold within the international segment, excluding non-recurring or non-operational charges. Monitoring this helps evaluate the production efficiency and supply chain cost structure specific to international operations.